Targeted Anticytokine Therapy in Patients With Chronic Heart FailureDouglas L. Mann, Thomas R. Fleming, Peter Liu et al.|Circulation|2004Cited by 1.2k
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled studyChristian J. Hendriksz, Wolfgang Dummer, Barbara K. Burton et al.|Journal of Inherited Metabolic Disease|2014Cited by 211
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoidRonald M. Bukowski, Catherine M. Tangen, Robert F. Peterson et al.|Cancer|1994Cited by 89
When to update COVID-19 vaccine compositionRebecca Grant, Kanta Subbarao, Jilian A. Sacks et al.|Nature Medicine|2023Cited by 51
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is VaccinatedDean Follmann, Kathleen M. Neuzil, Jonathan Fintzi et al.|Annals of Internal Medicine|2021Cited by 26